1Banks R C, Torks M A, Kinsey S E, et al. Release of the angiogenesis cytokin vascular endothelia growth factor (VEGF) from platelets: significance for VEGF measurments and cancer biology. Br J Cancer, 1998, 77:958-964.
2Vacca A, Ria R, Ribatti D, et al. A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma. Haematologia, 2003, 88:176-176.
3Salven P, Teerenhori L, Joensue H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcom in non-Hodgkin, s lymphoma. Blood, 1997, 90:3167-3172.
4Yetgin S, Yenicesu I, Cetin I, et al. Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia. Leuk Lymphoma, 2001, 42(1-2):83-88.
5Bataille R, Boccadoro M, Klein B, et al. C-reactive protein and β2-microglobulin produce a simple and powerful myeloma staging system. Blood, 1992, 79:733-740.
同被引文献6
1POTTI A, GANTI A K, KARGAS S, et al. Immunohistochemical detection of C-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma[J]. Anticancer Res,2002, 22:2899-2901.
2BELLAMY W T, RICHTER L, FRUTIGER Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies [J].Cancer Res, 1999, 59:728--733.
3MASOOD R, CAI J, ZHENG T, et al. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma[J]. Proc Natl Acad Sci, 1997, 94:979--984.
4BOSARI S, LEE A K, DELELLIS R A, et al. Microvessel quantitation and prognosis in invasive breast carcinoma[J]. Hum Pathol, 1992, 23:755--761.
5SHI W, SIEMANN D W. Inhibition of renal cell carcinoma angiogenesis and growth by antisense oligonucleotides targeting vascular endothelial growth factor[J]. Br J Cancer, 2002, 87:119--126.
6HO C L, SHEU L F, LI C Y. Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage Ⅳ non-Hodgkin lymphoma[J]. Appl Immunohistochem Mol Morphol, 2002, 10:316-321.
